|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.610 USD | -5.37% |
|
-3.36% | +66.08% |
| 07-14 | Cumberland Pharmaceuticals Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
| 07-13 | Cumberland Pharmaceuticals Announces Special Dividend, Payable on July 31, 2026 | CI |
| Market Cap | 99.04M 86.99M 80.89M 74.23M 139M 9.54B 142M 961M 375M 4.69B 372M 364M 16.21B | P/E 2024 |
-5.14x | P/E 2025 | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 97.77M 85.88M 79.86M 73.28M 138M 9.42B 140M 948M 371M 4.63B 367M 359M 16.01B | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 1.31x |
| Free-Float |
57.09% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cumberland Pharmaceuticals Inc.
| 1 day | -5.37% | ||
| 1 week | -3.36% | ||
| Current month | +2.01% | ||
| 1 month | +9.26% | ||
| 3 months | +62.81% | ||
| 6 months | +68.19% | ||
| Current year | +66.08% |
| 1 week | 5.75 |  | 8.06 |
| 1 month | 5.75 | | 8.09 |
| Current year | 2.69 | | 8.09 |
| 1 year | 1.85 | | 8.09 |
| 3 years | 1.04 | | 8.09 |
| 5 years | 1.04 | | 8.09 |
| 10 years | 0 | | 8.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 67 | 07/01/1999 |
John Hamm
DFI | Director of Finance/CFO | 70 | 17/05/2021 |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CHM | Chairman | 67 | 07/01/1999 |
| Director/Board Member | 74 | 10/09/2010 | |
James Jones
BRD | Director/Board Member | 78 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/03/26 | Free | Executive/Senior Manager | 3,000 | 0.0201% | ||
| 18/03/26 | Free | Director | 1,800 | 0.0120% | ||
| 18/03/26 | Free | Director | 1,800 | 0.0120% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.37% | -3.36% | +96.73% | +337.75% | 99.04M | |
| +0.86% | +1.43% | +48.50% | +160.39% | 1,067B | |
| +1.59% | +4.09% | +55.34% | +53.96% | 635B | |
| +0.95% | +1.91% | +35.91% | +81.14% | 458B | |
| +1.60% | +6.25% | +33.95% | +29.84% | 347B | |
| -0.60% | +1.52% | +35.68% | +39.76% | 295B | |
| -0.14% | +0.60% | +16.17% | +17.53% | 262B | |
| +0.09% | -2.82% | -28.29% | -41.71% | 216B | |
| +1.22% | +2.66% | +21.87% | +59.73% | 203B | |
| -1.18% | -3.70% | +14.23% | +66.51% | 161B | |
| Average | -0.20% | +0.86% | +33.01% | +80.49% | 364.31B | |
| Weighted average by Cap. | +0.55% | +1.95% | +35.81% | +77.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 37.87M 33.26M 30.93M 28.38M 53.33M 3.65B 54.15M 367M 143M 1.79B 142M 139M 6.2B | 44.52M 39.1M 36.37M 33.37M 62.7M 4.29B 63.67M 432M 169M 2.11B 167M 164M 7.29B |
| Net income | -6.48M -5.69M -5.29M -4.86M -9.13M -624M -9.27M -62.85M -24.55M -307M -24.33M -23.8M -1.06B | -2.84M -2.49M -2.32M -2.13M -3.99M -273M -4.06M -27.51M -10.75M -134M -10.65M -10.42M -464M |
| Net Debt | 2.61M 2.29M 2.13M 1.95M 3.67M 251M 3.73M 25.3M 9.88M 123M 9.79M 9.58M 427M | -1.26M -1.11M -1.03M -948K -1.78M -122M -1.81M -12.26M -4.79M -59.85M -4.75M -4.64M -207M |
Employees
93
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | $6.610 | -5.37% | 123,409 |
| 23/07/26 | $6.985 | -1.83% | 419,000 |
| 22/07/26 | $7.115 | -9.36% | 147,811 |
| 21/07/26 | $7.850 | +7.53% | 137,146 |
| 20/07/26 | $7.300 | +6.73% | 119,792 |
- Stock Market
- Stocks
- CPIX Stock
Select your edition
All financial news and data tailored to specific country editions
